Terms: = Lung cancer AND SND1, Q7KZF4, TDRD11, p100, ENSG00000197157, 27044 AND Treatment
7 results:
1. Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance.
Zhang X; Maity TK; Ross KE; Qi Y; Cultraro CM; Bahta M; Pitts S; Keswani M; Gao S; Nguyen KDP; Cowart J; Kirkali F; Wu C; Guha U
Cancer Res; 2021 Jun; 81(11):3051-3066. PubMed ID: 33727228
[TBL] [Abstract] [Full Text] [Related]
2. OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3.
Zhang B; Yang C; Wang R; Wu J; Zhang Y; Liu D; Sun X; Li X; Ren H; Qin S
J Exp Clin Cancer Res; 2020 Nov; 39(1):244. PubMed ID: 33198776
[TBL] [Abstract] [Full Text] [Related]
3. p52 Overexpression Increases Epithelial Apoptosis, Enhances lung Injury, and Reduces Survival after Lipopolysaccharide treatment.
Saxon JA; Cheng DS; Han W; Polosukhin VV; McLoed AG; Richmond BW; Gleaves LA; Tanjore H; Sherrill TP; Barham W; Yull FE; Blackwell TS
J Immunol; 2016 Feb; 196(4):1891-9. PubMed ID: 26773153
[TBL] [Abstract] [Full Text] [Related]
4. MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.
Ma F; Song H; Guo B; Zhang Y; Zheng Y; Lin C; Wu Y; Guan G; Sha R; Zhou Q; Wang D; Zhou X; Li J; Qiu X
Oncotarget; 2015 Jul; 6(19):17404-16. PubMed ID: 25965817
[TBL] [Abstract] [Full Text] [Related]
5. p52-Independent nuclear translocation of RelB promotes LPS-induced attachment.
Saito T; Sasaki CY; Rezanka LJ; Ghosh P; Longo DL
Biochem Biophys Res Commun; 2010 Jan; 391(1):235-41. PubMed ID: 19903458
[TBL] [Abstract] [Full Text] [Related]
6. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP).
Matta H; Chaudhary PM
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9399-404. PubMed ID: 15190178
[TBL] [Abstract] [Full Text] [Related]
7. Urinary-derived monocyte-colony stimulating factor (P-100) following treatment with carboplatin and etoposide in small cell lung cancer (SCLC).
Van Hoef ME; Radford JA; Jones A; Smith IE; Earl HM; Woll PJ; Thatcher N
Ann Oncol; 1993 Dec; 4(10):877-81. PubMed ID: 8117608
[TBL] [Abstract] [Full Text] [Related]
